Below is a list summarizing the CPT codes for the lower extremity application of splints.
CPT 29505 describes the application of a long leg splint from the thigh to the ankle or toes.
CPT 29515 describes the application of a short leg splint from the calf to the foot.
CPT 92551 is a screening test for pure tone, air only, used to detect hearing problems. This article will cover the description, procedure, qualifying circumstances, billing guidelines, documentation requirements, historical information, similar codes, and examples of CPT 92551. 1. What is CPT 92551? CPT 92551 is a Current Procedural Terminology (CPT) code used to describe…
CPT code 93970 illustrates the duplex scan of extremity veins, including responses to compression and other maneuvers, complete bilateral study. The CPT code 93970, preserved and described by American Medical Association (AMA), is a medical diagnostic, procedural code for non-invasive extremity venous studies. Duplex scanning to evaluate blood flow is a non-invasive diagnostic technique. First,…
Tonsillectomy CPT code(s) 42820, 42821, 42825, 42826 bills for service when the Physician performs a Tonsillectomy and adenoidectomy or a primary or secondary Tonsillectomy under the age of 12 or over 12 years. Tonsillectomy CPT Code Description The following are the reasons why the Physician performs Tonsillectomy: The patient may suffer from bleeding in the…
Below is a list summarizing the CPT codes for body and upper extremity application of strapping-any age. CPT Code 29200 CPT 29200 describes the strapping of the thorax. CPT Code 29240 CPT 29240 describes strapping of the shoulder, such as Velpeau strapping. CPT Code 29260 CPT 29260 describes the strapping of the elbow or wrist….
Below is a list summarizing the CPT codes for implantable, insertable, and wearable cardiac device evaluations. CPT Code 93260 CPT 93260 describes programming device evaluation (in person) with iterative adjustment of the implantable device to test the device’s function, selection of optimal permanent programmed values, analysis, review, and report by a physician or other qualified…
Sipuleucel-T (trade name Provenge) is the first autologous cellular immunotherapy and this is the first immunotherapy for prostate cancer to receive FDA approval. Sipuleucel-T consists of autologous peripheral blood mononuclear cells (PBMCs), including antigen presenting cells, that have been activated with PAP-GM-CSF, a recombinant human protein. PAP-GM-CSF consists of prostatic acid phosphatase (PAP), an antigen…
